Free Trial

RenovoRx (RNXT) News Today

RenovoRx logo
$1.02 -0.01 (-0.97%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.02 0.00 (0.00%)
As of 04/17/2025 05:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
RenovoRx ramps up production of FDA-cleared RenovoCath
Renovo Gains on Bringing Forward RenovoCath
RenovoRx lance une offre publique d'actions
RenovoRx launches public stock offering
RenovoRx announces common stock offering, no amount given
RenovoRx Announces Proposed Public Offering
RenovoRx Announces Proposed Public Offering
RenovoRx announces SCRI Oncology partners enrolling patients for trial
RenovoRx receives first purchase orders for FDA-cleared RenovoCath
RenovoRx augmente la production de son système RenovoCath
Get RenovoRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter.

RNXT Media Mentions By Week

RNXT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RNXT
News Sentiment

0.46

0.58

Average
Medical
News Sentiment

RNXT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RNXT Articles
This Week

13

1

RNXT Articles
Average Week

Get RenovoRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNXT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:RNXT) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners